← Back to headlines
Relmada Therapeutics Among Best Growth Stocks Under $30
Relmada Therapeutics (RLMD) is listed as one of the top 10 growth stocks priced under $30, suggesting it is a favorable investment opportunity.
19 Jun, 07:01 — 19 Jun, 07:01
Sources
Showing 1 of 1 sources
